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Background
We recently demonstrated that intradermal (ID) injection
with electroporation (EP) of a new HIV DNA vaccine
(auxo-GTU®MultiHIV) induced particularly strong and
very long lasting specific T-cell responses (1044 ± 400 SFC
per million PBMCs 3 years after vaccination) in
macaques. Therefore we get interested to characterize the
localization and expression of the auxo-GTU®MultiHIV
vaccine as well as local involvement of immune cells at
the sites of injection and in draining lymph nodes (LN).
Methods
Auxo-GTUMultiHIV DNA vaccine encoded consensus
Gag, Nef, Rev, and Tat proteins from HIV clade B. In addi-
tion, this plasmid exploits the transcription enhancer and
partioning capacity of the bovine papillomavirus (BPV)
protein E2. ID injection was followed by EP with topical
electrodes. Skin and LN biopsies were performed at differ-
ent time points after ID injection and frozen in OCT
media for immunochemistry analysis with fluorescence
labelled mAbs. In vivo imaging was performed by ID
injection and EP of the similar plasmid that expresses luci-
ferase. Detection was done after injection of luciferin sub-
strate.
Results
EP strongly increased DNA vaccine expression in the epi-
dermis after ID injection. Peak of DNA expression was
detected 24 hours after vaccination, and at day 8, was lim-
ited to the external layer of keratinocytes. The frequency of
CD1a+ cells increased in the epidermis until day 8. Mean-
while CD1a+ cells were detected in the draining LN in
association with antigen expression.
Conclusion
EP after ID injection of the auxo-GTU®MultiHIV DNA vac-
cine favoured plasmid expression in the epidermis. This
may suggest the involvement of Langerhans cells in the
subsequent generation and persistence of T cell responses.
This new approach which targets antigen expression in the
epidermis should be considered for T cell based prophy-
lactic and therapeutic vaccine design.
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